BORA PHARMACEUTICALS LTD (6472) — Net Asset Momentum
BORA PHARMACEUTICALS LTD (6472) recorded a net asset momentum of 16.4% as of September 2025, with net assets of NT$17.47 Billion TWD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See BORA PHARMACEUTICALS LTD defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
BORA PHARMACEUTICALS LTD Net Asset Momentum (2019–2025)
This chart tracks BORA PHARMACEUTICALS LTD's year-over-year net asset growth across 7 annual reporting periods from 2019 to 2025. The most recent momentum reading is +16.4%, with net assets of NT$17.47 Billion TWD as of September 2025. Read BORA PHARMACEUTICALS LTD debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for BORA PHARMACEUTICALS LTD (2019–2025)
The table below shows the complete annual net asset history for BORA PHARMACEUTICALS LTD from 2019 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is BORA PHARMACEUTICALS LTD worth.
| Year | Net Assets (TWD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | NT$17.47 Billion | NT$44.71 Billion | NT$27.24 Billion | ▲ +16.4% |
| 2024 | NT$15.01 Billion | NT$45.60 Billion | NT$30.59 Billion | ▲ +27.6% |
| 2023 | NT$11.77 Billion | NT$25.05 Billion | NT$13.29 Billion | ▲ +128.9% |
| 2022 | NT$5.14 Billion | NT$22.76 Billion | NT$17.62 Billion | ▲ +63.1% |
| 2021 | NT$3.15 Billion | NT$7.37 Billion | NT$4.22 Billion | ▲ +27.9% |
| 2020 | NT$2.46 Billion | NT$7.00 Billion | NT$4.54 Billion | ▲ +49.0% |
| 2019 | NT$1.65 Billion | NT$3.38 Billion | NT$1.73 Billion | — |